0001209191-15-069655.txt : 20150904
0001209191-15-069655.hdr.sgml : 20150904
20150904161619
ACCESSION NUMBER: 0001209191-15-069655
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150902
FILED AS OF DATE: 20150904
DATE AS OF CHANGE: 20150904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bertolino Arthur Peter
CENTRAL INDEX KEY: 0001426344
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 151094773
MAIL ADDRESS:
STREET 1: 6475 CHRISTIE AVENUE SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-09-02
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001426344
Bertolino Arthur Peter
C/O REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD
NEWARK
CA
94560
0
1
0
0
EVP and Chief Medical Officer
Common Stock
2015-09-02
4
F
0
3699
30.48
D
41754
D
Represents the number of shares withheld by and surrendered to the Issuer on September 2, 2015, to satisfy tax withholding obligations that arose in connection with the vesting of the Restricted Stock Award ("RSA") for 9,844 shares. The RSA vests in four equal annual installments from September 2, 2014, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Inducement Plan) on each vesting date.
/s/ Gordon Ho, Attorney-in-fact
2015-09-04